Hepatocellular Carcinoma - Clinical Research

preface_Hepatocellular Carcinoma – Clinical Research......Page 1 Part 1......Page 11 01_Hepatocellular Carcinoma: Epidemiology and Etiology......Page 13 02_The Relationship Between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma......Page 49 03_Recent Advances in the Immunohistochemistry- Aided Differential Diagnosis of Benign Versus Malignant Hepatocellular Lesions......Page 59 04_The Histomorphological and Immunohistochemical Diagnosis of Hepatocellular Carcinoma......Page 75 05_Signal Intensity Characteristics of Liver Masses at Hepatobiliary Phase Images of Gadoxetate-Enhanced MR (EOB-MR): Qualitative Assessment......Page 99 06_Differential Diagnosis of Hepatocellular Carcinoma on Computed Tomography......Page 115 07_Strategic Assay Developments for Detection of HBV 1762T/1764A Double Mutation in Urine of Patients with HBV-Associated Hepatocellular Carcinomas......Page 149 08_Usual and Unusual Gross Appearance of Hepatocellular Carcinomas......Page 165 Part 2......Page 191 09_Pure Laparoscopic Hepatectomy for HCC Patients......Page 193 10_Major Hepatectomy without Allogeneic Blood Transfusion for Hepatocellular Carcinoma......Page 207 Part 3......Page 219 11_Medical Management Options for Hepatocellular Carcinoma......Page 221 12_The Most Important Local and Regional Treatment Techniques of Hepatocellular Carcinoma and Their Effect over a Long Term Overall Survival......Page 235 13_Radiofrequency Ablation for Hepatocellular Carcinoma at the Dome of the Liver: A Review......Page 247 14_Transcatheter Arterial Chemo-Embolization with a Fine-Powder Formulation of Cisplatin for Unresectable Hepatocellular Carcinoma......Page 259 15_Transarterial Chemoembolization for HCC with Drug-Eluting Microspheres......Page 275 16_Therapy of Hepatocellular Carcinoma with Iodine-131-Lipidiol......Page 285 17_Future Trends in the Management of Advanced Hepatocellular Carcinoma (HCC)......Page 299 18_Systemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-Targeted Anti-Angiogenic Inhibitors......Page 319 19_Molecular Targeted Therapy for Growth Factors in Hepatocellular Carcinoma......Page 331